Advaxis updates median overall survival data from phase I/II study of ADXS-PSA in metastatic CRPC Oct. 8, 2019
Phase III extension study of VM-202 in diabetic peripheral neuropathy meets primary endpoint Oct. 8, 2019
H. Lee Moffitt Cancer Center and Research Institute presents YAP1/POU5F1 interaction inhibitors Oct. 8, 2019
RSS